The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Abstract Background The purpose of this study is to validate a new five-tiered prognostic classification system to better discriminate cancer-specific mortality in men diagnosed with primary non-metastatic prostate cancer. Methods We applied a recently described five-strata model, the Cambridge Prog...

Full description

Bibliographic Details
Main Authors: V. J. Gnanapragasam, O. Bratt, K. Muir, L. S. Lee, H. H. Huang, P. Stattin, A. Lophatananon
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Medicine
Subjects:
Prostate cancer
Prognostic prediction
Cancer-specific mortality
Cambridge Prognostic Groups
Non-metastatic disease
Stratification
Online Access:http://link.springer.com/article/10.1186/s12916-018-1019-5

Internet

http://link.springer.com/article/10.1186/s12916-018-1019-5

Similar Items